In this episode of the Personalized Medicine Podcast we talk about precision oncology with a scientist and serial entrepreneur, Dr. Gang Song. Gang completed his PhD degree in Biochemistry and Molecular Biology at the Shanghai Medical College of Fudan University and then moved to Harvard where he did a PostDoc at the lab of Tim Springer where he was studying structure and function of cell adhesion molecules. Gang has extensive experience in the life science industry working at various positions at IQuum, which was acquired by Roche, Genzyme Genetics and LabCorp. In 2014, Gang founded Pillar Biosciences, a precision medicine company developing genomics tests for various types of cancer. Gang also co-founded another venture, AffyImmune Therapeutics, which is focusing on developing novel cell therapies for cancer based on CAR-T cell technology.
Together with Gang we discussed:
👉 His career: from PhD in China to founding multiple successful biotech companies in the US
👉 Mentorship lessons from Professor Tim Springer
👉 Founding story of Pillar Biosciences
👉 Novel NGS approaches for early cancer detection
👉 Differences in business models pursued by diagnostics companies in oncology
👉 Next generation of CAR-T cell therapeutics
👉 Future of precision oncology
👉 Gang’s advice to aspiring biotech entrepreneurs
📃 Download the full show notes for this episode that include guest's bio, links to his most notable work, and additional reads on the topic of the episode at our website 👉 [ Ссылка ]
🎯 Don’t forget to subscribe to the Personalized Medicine Podcast on your favorite podcasting platform:
👉 Apple Podcasts: [ Ссылка ]
👉 Spotify: [ Ссылка ]
👉 Pocket Casts: [ Ссылка ]
👉 Stitcher: [ Ссылка ]
👉 Google Podcasts: [ Ссылка ]
📢 Follow us on social media:
👉 LinkedIn: [ Ссылка ]
👉 Twitter: [ Ссылка ]
👉 Facebook: [ Ссылка ]
#PrecisionMedicine #NGS #oncology
